A

Apellis Pharmaceuticals

Biotechnology Research · United States · 1,000 employees

98 Decision makers
+1 New (6 months)
1,000 Employees
$1.1B Revenue
2008 Founded

Organizational Chart of Apellis Pharmaceuticals

Roles identified within Apellis Pharmaceuticals's leadership team, from public professional data, updated 25 Oct 2026.

Department

Hiring This department is actively hiring right now.

Apellis Pharmaceuticals's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Apellis Pharmaceuticals by function

General management

Finance

Human resources

Other functions

See all Apellis Pharmaceuticals contacts on Zeliq

Decision makers at Apellis Pharmaceuticals

98 identified 5 C-Level 4 VP 89 Directors +1 new (6 months)
See them on Zeliq →

Departments actively hiring 4 departments

General management
Operations
Product
Sales

These departments at Apellis Pharmaceuticals are actively recruiting: a strong signal to time your outreach.

Funding and news at Apellis Pharmaceuticals

Funding

Last round Other · $193M
Total funding $1.5B (17 rounds)
Corporate Round N/A Jan 2008
Venture Round $2M May 2010
Series A $3M Jun 2011
Series B N/A Jul 2012
Non Equity Assistance $20K Apr 2013
Venture Round $18M Jul 2013
Venture Round $6M Aug 2013
Venture Round $18M Aug 2014
Series C $33M Dec 2014
Series D $47M Feb 2016
Series E $60M Aug 2017
Post-IPO Equity N/A Jan 2020
Post-IPO Equity $1M Apr 2022
Post-IPO Equity $402M Feb 2023
Post-IPO Debt $475M May 2024
Post-IPO Debt $275M Jul 2025
Post-IPO Equity $193M Feb 2026

Team Structure headcount by department

Medical
81
Hiring Sales
72
Hiring Operations
42
Research
37
Other
31
Hiring General Management
27
Finance
24
Project Management
21

How to prospect Apellis Pharmaceuticals's departments

Medical

With 81 people, this is the organisation's biggest team. Time with patients is the priority: position your solution as a way to give hours back to care.

Sales

A team of 72 people, currently hiring. Sales leaders respect good selling: a sharp, well-researched approach is your best credential.

Operations

This 42-person department is actively recruiting. Pitch measurable time savings and error reduction: the metrics this function is judged on.

Research

This department counts 37 people. Researchers respond to substance: reference publications, benchmarks or datasets relevant to their field.

General Management

Hiring is underway in this team of 27 people. A good executive approach often starts lower in the organisation: build an internal champion before going top-down.

Product

A team of 6 people, currently hiring. Product people are user-obsessed: bring insights about their users and you will stand out.

Try the Zeliq email finder demo →

FAQ Apellis Pharmaceuticals

Who runs Apellis Pharmaceuticals?

The highest-ranking leadership role identified at Apellis Pharmaceuticals is “CFO”, based on public data updated 25 Oct 2026.

How many decision makers does Apellis Pharmaceuticals have?

98 decision makers identified, including 5 at executive level.

How do I contact a decision maker at Apellis Pharmaceuticals?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Which departments are hiring at Apellis Pharmaceuticals?

General management, Operations and Product, based on published job offers as of 25 Oct 2026.

Companies similar to Apellis Pharmaceuticals

More companies to explore

Biotechnology Research · United States

All Biotechnology Research companies in United States →

About Apellis Pharmaceuticals

Apellis Pharmaceuticals is a business specialised in Biotechnology Research, operating from United States. Founded in 2008, the company counts about 1,000 employees. Apellis Pharmaceuticals belongs to the Professional Services sector, with a specific positioning on Biotechnology Research. Its customer base is mainly professional: Apellis Pharmaceuticals operates on a B2B model. The company has secured 17 rounds of funding totalling $1.5B. The company generates approximately $1.1B in annual revenue. Sales teams can rely on this profile to qualify Apellis Pharmaceuticals, spot business signals, and connect with verified decision makers.

Activity & Market

The company evolves in the Biotechnology Research segment of the Professional Services sector. As a B2B company, Apellis Pharmaceuticals primarily serves business clients and professional organisations. The company is categorised as “Public company”.